Modulation of tardive dyskinesia by estrogen: neurochemical studies in an animal model
Gordon, J.H.; Diamond, B.I.
Transactions of the American Neurological Association 104: 97-100
1979
ISSN/ISBN: 0065-9479 PMID: 553438 Document Number: 153407
Document emailed within 1 workday
Related Documents
Bhattachary, S.K.; Bhattacharya, D.; Muruganandam, A.V. 2000: Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia Indian Journal of Experimental Biology 38(9): 945-947Rubovits, R. 1977: Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model Psychopharmacology Bulletin 13(1): 49-50
Glazer, W.M. 2000: Review of incidence studies of tardive dyskinesia associated with typical antipsychotics Journal of Clinical Psychiatry 61(Suppl): 15-20
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Staton, R.D.; Brumback, R.A. 1980: Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis) Journal of Clinical Psychiatry 41(12 Part 1): 427-428
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Gualtieri, C.T.; Breuning, S.E.; Schroeder, S.R.; Quade, D. 1982: Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies Psychopharmacology Bulletin 18(1): 62-65
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Takahama, K.; Shirasaki, T. 2001: Endocrine disruptors and brain estrogen receptors: the current state of behavioral, neurochemical, and molecular biological studies Nihon Shinkei Seishin Yakurigaku Zasshi 21(4): 103-111
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Carta, M.G.; Hardoy, M.C.; Dell'Osso, L.; Carpiniello, B. 2004: Tardive dyskinesia: review of the literature La Clinica Terapeutica 155(4): 127-133
Bjørndal, F. 1982: Tardive dyskinesia following metoclopramide (Primperan) Ugeskrift for Laeger 144(12): 878-879